Tropical Storm Pilar unleashes havoc: Fatalities and fear grip Central America

Tropical Storm Pilar unleashes havoc: Fatalities and fear grip Central America

Tropical Storm Pilar, a menacing force off the Pacific Coast, has been wreaking unprecedented havoc across Central America. As the storm intensifies, its ruthless nature is becoming painfully clear – crops destroyed, hundreds displaced, and a mounting death toll now standing at four. The destruction began on Sunday, with three fatalities in El Salvador and […]

Pearl Global Industries takes majority stake in Guatemala-based Pearl GT Holdco

Pearl Global Industries takes majority stake in Guatemala-based Pearl GT Holdco

Indian garment exporter Pearl Global Industries Limited (PGIL) has declared a significant strategic expansion into Guatemala, acquiring a majority 55% stake in Pearl GT Holdco Ltd. for $550,000. The venture aims to exploit the manufacturing and trading capabilities of Guatemalan companies Shoretex Sociedad Anonima (Shoretex) and Corporacion de Productos y Servicios Asociados, Sociedad Anonima (Corpasa), […]

Tahoe Resources cuts 200 more jobs at Escobal silver mine in Guatemala

Tahoe Resources cuts 200 more jobs at Escobal silver mine in Guatemala

Tahoe Resources, a US-based precious metals producer, said that it has dismissed nearly 200 employees at its troubled Escobal silver mine in Guatemala where mining operations had been suspended for more than a year. The Escobal silver mine, which is located in the Santa Rosa Department, and operated by Tahoe Resources’ Minera San Rafael, is […]

Dengvaxia : Sanofi Pasteur rolls out world’s first dengue vaccine in Guatemala

Dengvaxia : Sanofi Pasteur rolls out world’s first dengue vaccine in Guatemala

Sanofi Pasteur, the French pharmaceutical giant, has announced the rollout of Dengvaxia, the world’s first dengue vaccine, in Guatemala in the upcoming days. This significant development was revealed at a news conference in Guatemala City, marking a crucial step in the fight against dengue fever, a mosquito-borne viral infection that poses severe global health challenges. […]

Amgen’s Parsabiv receives EC approval in secondary hyperparathyroidism

Amgen’s Parsabiv receives EC approval in secondary hyperparathyroidism

Amgen Inc., a leading American biopharmaceutical company, has achieved a significant milestone with the approval of its drug Parsabiv (etelcalcetide) by the European Commission (EC) for the treatment of secondary hyperparathyroidism (sHPT) in adult patients undergoing hemodialysis due to chronic renal disease. Breakthrough in sHPT Management sHPT is a complex and chronic condition that affects […]